TITLE

Should obesity be treated?

AUTHOR(S)
Garrow, J.S.
PUB. DATE
September 1994
SOURCE
BMJ: British Medical Journal (International Edition);9/10/94, Vol. 309 Issue 6955, p654
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Tackles the question on the necessity to treat obesity. Disabilities associated with obesity; Question on the possibility of achieving normal weight by severely obese patient; Dangers of inadequate treatment; Approach suggested by the author in the management of obesity.
ACCESSION #
4929202

 

Related Articles

  • Management of Obesity in Adults. Brunton, Stephen A. // Journal of Family Practice;Jul2014 Supplement, Vol. 63, pS1 

    An introduction is presented in which the author discusses various articles within the issue on topics including on the epidemiology and pathophysiology of obesity in adults, the significance of good communications with obese and overweight patients, and obesity management.

  • NIH Clinical Guidelines on Obesity: A Summary.  // Healthy Weight Journal;Mar/Apr1999, Vol. 13 Issue 2, p20 

    Focuses on guidelines issued by the United States National Institutes of Health on obesity treatment. Information on obesity; Prevalence of obesity in the country; Persons at risk of being overweight; Therapeutic approaches to obesity; Goals for weight loss and management.

  • Health promotion strategies for obese patients. Miller, Wayne C. // Healthy Weight Journal;May/Jun97, Vol. 11 Issue 3, p47 

    Discusses intervention strategies for promoting health in obese persons. Ineffectiveness of diet programs; Absence of evidence linking reduced mortality to weight loss; Behavioral self-monitoring; Exercise; Food intake; Psychologic component of intervention plan.

  • Childhood obesity: Etiology and treatment. Levick, Keith // Healthy Weight Journal;Sep/Oct94, Vol. 8 Issue 5, p89 

    Explores changing family dynamics that affect many children adversely and contribute to problems such as increasing levels of overweight. Warning that overweight children should not be put on diet; Guidelines for safe treatment programs.

  • Severe obesity and personality: a comparative controlled study of personality traits. Rydén, A.; Sullivan, M.; Torgerson, J.S.; Karlsson, J.; Lindroos, A.-K.; Taft, C. // International Journal of Obesity & Related Metabolic Disorders;Dec2003, Vol. 27 Issue 12, p1534 

    OBJECTIVE:: The primary purpose was to assess personality trait differences between the severely obese seeking treatment and a mainly non-obese reference group. We also investigated gender differences and differences between obese patients and obese not seeking treatment. METHOD:: Personality...

  • New obesity treatment approved. Maudlin, Robert K. // Modern Medicine;Jun99, Vol. 67 Issue 6, p50 

    Reports on the approval of Orlistat (Xenical) for obesity management. Initial body max index of obese patients to whom the therapy is recommended; Findings of the clinical trials on Orlistat-treated subjects; Most commonly observed adverse effects during the first year of therapy.

  • Overweight patients. Gibbons, Pamela // British Medical Journal (Clinical Research Edition);3/28/1981, Vol. 282 Issue 6269, p1060 

    Focuses on the management of overweight patients. Tips on dieting; Objective of obese treatment; Need of long-term supervision from doctors.

  • NIH Guidelines: An Evaluation. Berg, Frances M. // Healthy Weight Journal;Mar/Apr1999, Vol. 13 Issue 2, p26 

    Comments on the guidelines issued by the United States National Institutes of Health on the treatment of obesity. Basic assumptions underlying the guidelines; Description of people at risk of developing obesity; Average body mass index specified in the guidelines; Validity of treatment...

  • A clinical trial of the use of Sibutramine for the treatment of patients suffering essential obesity. Fanghänel, G; Cortinas, L; Sánchez-Reyes, L; Berber, A // International Journal of Obesity & Related Metabolic Disorders;Feb2000, Vol. 24 Issue 2, p144 

    OBJECTIVE: To evaluate the safety and efficacy of Sibutramine 10 mg per os, once a day in obese patients over a period of 6 months. DESIGN: A monocenter, double-blind, placebo-controlled, parallel, prospective clinical trial. SUBJECTS: 109 male and female obese patients (BMI >30 kg/m²) from...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics